Virtual Event
- This event has passed.
Advancing iPSC Therapies Toward Commercialization: Key Challenges and Acceleration Strategies
May 19 @ 10:00 am - 11:00 am
Virtual Event
Translating iPSC-based therapies from research to clinical application requires overcoming key challenges in scalable manufacturing, including process efficiency, product quality, and regulatory compliance. This presentation explores practical strategies to improve iPSC expansion and differentiation, with a focus on ECM proteins such as Laminin 521/511 and GMP-compliant systems that support robust, scalable, and automation-ready workflows.
Key Highlights
- Strategies to enhance iPSC expansion and differentiation efficiency
- The role of ECM proteins (Laminin 521/511) in maintaining cell stability and quality
- Approaches to ensure genetic stability, pluripotency, and high-purity cell populations
- Functional validation of iPSC-derived cells (e.g., NK cells, islet cells)
- Key considerations for GMP compliance, safety control, and scalable manufacturing
Hosted by:
